本周的《自然》杂志上刊登了一项来自瑞士巴塞尔大学的研究，Michael N. Hall带领的研究团队发现了一种全新的抑癌蛋白LHPP，这种蛋白的丧失促进了肿瘤的生长，增加LHPP表达则能够有效抑制癌细胞增殖并阻止肝功能损伤[1]！除此之外，LHPP水平也与疾病负担和患者预后有关，研究者认为可以作为诊断和预后的生物指标。
[2] Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 2,16018–16023 (2016).
[3] Schulze, K. et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat. Genet. 47,505–511 (2015).
[4] Kenerson, H. L. et al. Akt and mTORC1 have different roles during liver tumorigenesis in mice. Gastroenterology 144, 1055–1065 (2013).
[5] Guri, Y. et al. mTORC2 promotes tumorigenesis via lipid synthesis. Cancer Cell 32, 807–823 (2017).
[6] Makowska, Z. et al. Gene expression analysis of biopsy samples reveals critical limitations of transcriptome-based molecular classifcations of hepatocellular carcinoma. J. Pathol. Clin. Res. 2, 80–92 (2016).
[7] Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546–1558(2013).
[8] Vijayakrishnan, J. et al. A genome-wide association study identifes risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1. Leukemia 31, 573–579 (2017).
[9] Lesseur, C. et al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat. Genet. 48, 1544–1550 (2016).
